BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8580807)

  • 1. Transient leukemia followed by megakaryoblastic leukemia in a child with mosaic Down syndrome.
    Doyle JJ; Thorner P; Poon A; Tanswell K; Kamel-Reid S; Zipursky A
    Leuk Lymphoma; 1995 Apr; 17(3-4):345-50. PubMed ID: 8580807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Megakaryoblastic leukemia and Down's syndrome: a review.
    Zipursky A; Peeters M; Poon A
    Pediatr Hematol Oncol; 1987; 4(3):211-30. PubMed ID: 2978961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient myelodysplasia in an infant with Down syndrome preceding acute megakaryoblastic leukemia: cytogenetic and immunophenotypic findings.
    Rodrigues EF; da Costa ES; Land MG; Diamond HR; Ornellas MH; Abdelhay E; Fernandez Tde S
    Cancer Genet Cytogenet; 2009 Jan; 188(1):54-6. PubMed ID: 19061782
    [No Abstract]   [Full Text] [Related]  

  • 4. GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.
    Hitzler JK; Cheung J; Li Y; Scherer SW; Zipursky A
    Blood; 2003 Jun; 101(11):4301-4. PubMed ID: 12586620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute megakaryoblastic leukemia in Down syndrome.
    Hitzler JK
    Pediatr Blood Cancer; 2007 Dec; 49(7 Suppl):1066-9. PubMed ID: 17943965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrasomy 21 transient leukemia with a GATA1 mutation in a phenotypically normal trisomy 21 mosaic infant: case report and review of the literature.
    Sandoval C; Pine SR; Guo Q; Sastry S; Stewart J; Kronn D; Jayabose S
    Pediatr Blood Cancer; 2005 Jan; 44(1):85-91. PubMed ID: 15390279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origins of leukaemia in children with Down syndrome.
    Hitzler JK; Zipursky A
    Nat Rev Cancer; 2005 Jan; 5(1):11-20. PubMed ID: 15630411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Janus kinase mutations in the development of acute megakaryoblastic leukemia in children with and without Down's syndrome.
    Klusmann JH; Reinhardt D; Hasle H; Kaspers GJ; Creutzig U; Hahlen K; van den Heuvel-Eibrink MM; Zwaan CM
    Leukemia; 2007 Jul; 21(7):1584-7. PubMed ID: 17443226
    [No Abstract]   [Full Text] [Related]  

  • 9. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
    Reinhardt D; Reinhardt K; Neuhoff C; Sander A; Klusmann JH; Pekrun A; Sauerbrey A; von Stackelberg A; Rössig C; Creutzig U; Kolenova A
    Klin Padiatr; 2012 Apr; 224(3):153-5. PubMed ID: 22513796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute megakaryoblastic leukemia associated with mosaic Down's syndrome.
    Simon JH; Tebbi CK; Freeman AI; Brecher ML; Green DM; Sandberg AA
    Cancer; 1987 Nov; 60(10):2515-20. PubMed ID: 2959356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of acute megakaryoblastic leukemia from a minor clone in a Down syndrome patient with clinically overt transient myeloproliferative disorder.
    Xu G; Kato K; Toki T; Takahashi Y; Terui K; Ito E
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):696-8. PubMed ID: 17023834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down syndrome and GATA1-related transient leukemia.
    Sandoval C; Pine SR
    J Pediatr; 2007 Mar; 150(3):e34. PubMed ID: 17307526
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydrops fetalis and neonatal leukemia in Down syndrome.
    Zipursky A; Rose T; Skidmore M; Thorner P; Doyle J
    Pediatr Hematol Oncol; 1996; 13(1):81-7. PubMed ID: 8718505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute leukemias in children with Down syndrome.
    Seewald L; Taub JW; Maloney KW; McCabe ER
    Mol Genet Metab; 2012 Sep; 107(1-2):25-30. PubMed ID: 22867885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prominent megakaryocytic dysplasia after regression of transient abnormal myelopoiesis associated with GATA-1 mutation.
    Anoop P; Atra A
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):640. PubMed ID: 23007419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia.
    Crispino JD
    Pediatr Blood Cancer; 2005 Jan; 44(1):40-4. PubMed ID: 15390312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome copy number and leukemia-lessons from Down's syndrome.
    Izraeli S
    Hematology; 2005; 10 Suppl 1():164-6. PubMed ID: 16188662
    [No Abstract]   [Full Text] [Related]  

  • 18. Downs' syndrome with acute myeloid leukemia.
    Tauro S
    J Assoc Physicians India; 1995 Feb; 43(2):148. PubMed ID: 9282697
    [No Abstract]   [Full Text] [Related]  

  • 19. Ultrastructural studies of the megakaryoblastic leukemias of Down syndrome.
    Zipursky A; Christensen H; De Harven E
    Leuk Lymphoma; 1995 Jul; 18(3-4):341-7. PubMed ID: 8535203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder.
    Cushing T; Clericuzio CL; Wilson CS; Taub JW; Ge Y; Reichard KK; Winter SS
    J Pediatr; 2006 May; 148(5):687-9. PubMed ID: 16737888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.